| Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169) |
|---|
| 05/18/2000 | CA2349498A1 Methods and compositions for treating or preventing peripheral neuropathies |
| 05/18/2000 | CA2348946A1 Cystine derivatives as therapeutic agents for matrix metalloprotease related diseases |
| 05/18/2000 | CA2347916A1 Inhibition of the formation of vascular hyperpermeability |
| 05/18/2000 | CA2345459A1 Bicyclic signal transduction inhibitors, compositions containing them & uses thereof |
| 05/17/2000 | EP1000930A2 Tachykinin antagonists |
| 05/17/2000 | EP1000618A1 Topical capsaicin preparation |
| 05/17/2000 | EP1000158A1 Endogenetic retroviral sequences, associated with autoimmune diseases or with pregnancy disorders |
| 05/17/2000 | EP1000084A1 123 human secreted proteins |
| 05/17/2000 | EP1000064A1 Compounds |
| 05/17/2000 | EP1000060A1 Novel compounds |
| 05/17/2000 | EP1000055A1 SUBSTITUTED PYRAZOLES AS p38 KINASE INHIBITORS |
| 05/17/2000 | EP1000051A1 Carbamyloxy compounds which inhibit leukocyte adhesion mediated by vla-4 |
| 05/17/2000 | EP1000044A1 Benzothia(oxa)diazol derivatives and their use as endothelin-receptor antagonists |
| 05/17/2000 | EP1000040A1 Il-5 inhibiting 6-azauracil derivatives |
| 05/17/2000 | EP1000038A1 Novel pyrimidin derivatives |
| 05/17/2000 | EP1000035A1 Substituted 6-phenylphenanthridines |
| 05/17/2000 | EP1000034A1 Substituted 6-alkylphenanthridines |
| 05/17/2000 | EP1000031A1 Vitronectin receptor antagonist |
| 05/17/2000 | EP1000029A1 (+)-norcisapride useful for 5-ht3 and 5-ht4 mediated disorders |
| 05/17/2000 | EP1000018A2 Urokinase inhibitors |
| 05/17/2000 | EP1000017A1 Il-8 receptor antagonists |
| 05/17/2000 | EP0999856A2 Radiopharmaceuticals for imaging infection and inflammation |
| 05/17/2000 | EP0999854A1 Switchable viscoelastic systems containing galactomannan polymers and borate |
| 05/17/2000 | EP0999842A1 Novel substituted imidazole compounds |
| 05/17/2000 | EP0999831A1 Use of petroselinum acid for treating inflammations |
| 05/17/2000 | EP0791011B1 Biologically active tgf-beta1 and tgf-beta2 peptides |
| 05/17/2000 | EP0731706B1 Use of dimeticone for the manufacture of a medicament for treating aphthae and stomatitis |
| 05/17/2000 | EP0726768B1 Use of nitric oxide releasing compounds for the manufacture of a medicament for protection in ischemia reperfusion injury |
| 05/17/2000 | EP0644764B1 Lipids for epidermal moisturization and repair of barrier function |
| 05/17/2000 | EP0601106B1 Morphogen-induced modulation of inflammatory response |
| 05/17/2000 | CN1253567A Cell surface molecule mediating cell adhesion and signal transmission |
| 05/17/2000 | CN1253560A Sulfonamides for treatment of endothelin-mediated disorders |
| 05/17/2000 | CN1253559A Sulfonyl divalent aryl alpha-hydroxamic acid compounds |
| 05/17/2000 | CN1253558A Substituted imidazoles useful in treatment of inflammatory diseases |
| 05/17/2000 | CN1253555A Novel 2-(iminomethyl) amino-phenyl derivatives, preparation, application as medicines and pharmaceutical compositions containing same |
| 05/17/2000 | CN1253553A Substituted phenyl derivatives, their preparation and use |
| 05/17/2000 | CN1253545A Aryl sulfonamides and analogues thereof and their use in treatment of neurodegenerative diseases |
| 05/17/2000 | CN1253502A Method of using cyclooxygenase-2 inhibitors in prevention of cardiovascular disorders |
| 05/17/2000 | CN1253474A Sulfonyl divalent aryl or heteroaryl hydroxamic acid compounds |
| 05/17/2000 | CN1052489C Process for preparation of 16 alpha-methyl steroids |
| 05/17/2000 | CN1052418C Antalgic paster and its preparation method |
| 05/16/2000 | US6063811 Compositions for a once day treatment of cyclooxygenase-2 mediated diseases |
| 05/16/2000 | US6063807 Cyclo-oxygenase inhibitor and amidine derivatives salts, preparation method therefor, use thereof as drugs, and pharmaceutical compositions containing said salts |
| 05/16/2000 | US6063804 Pyrrole compounds |
| 05/16/2000 | US6063791 N-benzenesulfonyl-L-proline derivatives, method for preparing and therapeutic use |
| 05/16/2000 | US6063789 Antiinflammatory agents |
| 05/16/2000 | US6063609 Expression vector comprising an enzymatic protein; for use as diagnostic tools as well as antiarthritic, antiproliferative, anticarcinogenic, antitumor and antiinflammatory agents |
| 05/16/2000 | CA2215020C Tetrazolyl-substituted quinuclidines as substance p antagonists |
| 05/16/2000 | CA2180263C Diazabicyclic neurokinin antagonists |
| 05/16/2000 | CA2173403C External therapeutic composition for dermatitis |
| 05/16/2000 | CA2126752C Benzopyran and related ltb4 antagonists |
| 05/16/2000 | CA2065286C Treatment of chronic inflammatory conditions |
| 05/16/2000 | CA1340994C Treatment of conditions and disease |
| 05/13/2000 | CA2289329A1 A suppressive agent against expression of cell adhesion molecules |
| 05/11/2000 | WO2000026245A2 Human membrane transport proteins |
| 05/11/2000 | WO2000026243A2 Transmembrane 4 proteins |
| 05/11/2000 | WO2000026218A1 Tricyclic phthalazine derivatives as phosphodiesterase 4 inhibitors |
| 05/11/2000 | WO2000026216A1 Pyrazolopyridine derivatives as selective cox-2 inhibitors |
| 05/11/2000 | WO2000026212A1 Chromenone and chromanone derivatives as integrin inhibitors |
| 05/11/2000 | WO2000026208A1 N-oxides of heterocyclic compounds with tnf and pde-iv inhibiting activity |
| 05/11/2000 | WO2000026206A1 Method for producing luteolin and luteolin derivatives |
| 05/11/2000 | WO2000026201A1 Benzoylpyridazines |
| 05/11/2000 | WO2000026197A1 Novel inhibitors of impdh enzyme |
| 05/11/2000 | WO2000026192A1 Substituted 2-phenylbenzimidazoles, the production thereof and their use |
| 05/11/2000 | WO2000025817A1 Heparanase activity neutralizing anti-heparanase monoclonal antibody |
| 05/11/2000 | WO2000025791A1 Pyridin-4-yl or pyrimidin-4-yl substituted pyrazines |
| 05/11/2000 | WO2000025786A1 Heterocyclic potassium channel inhibitors |
| 05/11/2000 | WO2000025780A1 Compounds derived from an amine nucleus that are inhibitors of impdh enzyme |
| 05/11/2000 | WO2000025777A1 SUBSTITUTED PHENETHYLSULFONES AND METHOD OF REDUCING TNFαLEVELS |
| 05/11/2000 | WO2000025776A1 Nitrosated and nitrosylated nonsteroidal antiinflammatory compounds, compositions and methods of use |
| 05/11/2000 | WO2000025774A1 Benzamide potassium channel inhibitors |
| 05/11/2000 | WO2000025770A1 Carbocyclic potassium channel inhibitors |
| 05/11/2000 | WO2000025758A1 Oral administration of adenosine analogs |
| 05/11/2000 | WO2000025602A2 Use of calcareous material for foodstuff and cosmetic material |
| 05/11/2000 | WO2000013648A8 Method for the preparation of citalopram |
| 05/11/2000 | WO2000013015A8 Modulating multiple lineage kinase proteins |
| 05/11/2000 | WO2000008158A3 Molecules designated ldcam |
| 05/11/2000 | WO2000008007A3 Cyclopentabenzofuran derivatives and their use |
| 05/11/2000 | WO2000006769A3 Human ccr-2 gene polymorphisms |
| 05/11/2000 | WO1999060984A3 Compositions and methods for inhibiting endothelial cell proliferation and regulating angiogenesis using serine proteases |
| 05/11/2000 | DE19851184A1 N-Arylsulfonyl-aminosäure-omega-amide N-arylsulfonyl-amino-omega-amides |
| 05/11/2000 | DE19850701A1 Benzoylpyridazine Benzoylpyridazine |
| 05/11/2000 | CA2349818A1 Membrane transport proteins |
| 05/11/2000 | CA2349622A1 Heparanase activity neutralizing anti-heparanase monoclonal antibody |
| 05/11/2000 | CA2349567A1 Pyrazolopyridine derivatives as selective cox-2 inhibitors |
| 05/11/2000 | CA2349232A1 Benzoylpyridazines |
| 05/11/2000 | CA2348499A1 Use of calcareous material for foodstuff and cosmetic material |
| 05/11/2000 | CA2348446A1 Benzamide potassium channel inhibitors |
| 05/11/2000 | CA2348392A1 Method for producing luteolin and luteolin derivatives |
| 05/11/2000 | CA2348267A1 Novel inhibitors of impdh enzyme |
| 05/11/2000 | CA2348234A1 Compounds derived from an amine nucleus that are inhibitors of impdh enzyme |
| 05/11/2000 | CA2347650A1 Transmembrane 4 proteins |
| 05/11/2000 | CA2345337A1 Tricyclic phthalazine derivatives as phosphodiesterase 4 inhibitors |
| 05/11/2000 | CA2312430A1 N-oxides of heterocyclic compounds with tnf and pde-iv inhibiting activity |
| 05/10/2000 | EP0998572A2 Aggrecan degrading metallo proteases |
| 05/10/2000 | EP0998569A1 Polynucleotide encoding a polypeptide having heparanase activity and expression of same in transduced cells |
| 05/10/2000 | EP0998492A1 Composition and methods for the treatment of inflammatory diseases |
| 05/10/2000 | EP0998484A1 Tharapeutically active compounds with low systemic activity due to reduced half-life |
| 05/10/2000 | EP0998477A1 Alkyl-4-silylheterocyclic phenols and thiophenols as antioxidant agents |
| 05/10/2000 | EP0998460A1 Novel tetrazole derivatives |